FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric Patients

Kevin Chung

Medicine

Press/Media

Period	30 Oct 2023 → 31 Oct 2023

Media coverage

2

Media coverage

Title	FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric Patients
Media name/outlet	Wall Street Analyzer
Country/Territory	United States
Date	31/10/23
URL	https://wallstreetanalyzer.com/2023/10/31/fda-issues-approvable-letter-for-seastar-medicals-selective-cytopheretic-device-for-pediatric-patients/
Persons	Kevin Chung

Title	FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric Patients \| BioSpace
Media name/outlet	Zephyrnet.com
Country/Territory	United States
Date	30/10/23
URL	https://zephyrnet.com/fda-issues-approvable-letter-for-seastar-medicals-selective-cytopheretic-device-for-pediatric-patients-biospace/
Persons	Kevin Chung